DGAP-News: INJEX Pharma AG received FDA clearance for the import and sale of the needle free injection technology INJEX 30 into the US Market
DGAP-News: INJEX Pharma AG / Key word(s): Regulatory Approval
INJEX Pharma AG received FDA clearance for the import and sale of the
needle free injection technology INJEX 30 into the US Market
30.05.2012 / 16:20
———————————————————————
INJEX Pharma AG received FDA clearance for the import and sale of the
needle free injection technology INJEX 30 into the US Market
INJEX Pharma AG ISIN: DE000A0STYL7
Berlin, 30. M
